| The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease | 2018/05/14 | English | 386 |
| Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment | 2017/09/04 | English | 380 |
| Immunity, endothelial injury and complement-induced coagulopathy in COVID-19 | 2020/10/19 | English | 379 |
| Mechanisms and treatment of organ failure in sepsis | 2018/04/24 | English | 367 |
| Renal, metabolic and cardiovascular considerations of SGLT2 inhibition | 2016/12/12 | English | 367 |
| The Klotho proteins in health and disease | 2018/11/19 | English | 363 |
| Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies | 2012/10/02 | English | 361 |
| Complement in disease: a defence system turning offensive | 2016/05/23 | English | 360 |
| Immune cell dysfunction and inflammation in end-stage renal disease | 2013/03/19 | English | 359 |
| Changes in the worldwide epidemiology of peritoneal dialysis | 2016/12/28 | English | 335 |
| Immune cells in experimental acute kidney injury | 2014/10/21 | English | 332 |
| Mitochondrial dysfunction in diabetic kidney disease | 2018/02/19 | English | 328 |
| Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases | 2017/10/03 | English | 327 |
| Kidney involvement in COVID-19 and rationale for extracorporeal therapies | 2020/04/09 | English | 316 |
| Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery | 2017/10/30 | English | 311 |
| The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | 2018/12/03 | English | 307 |
| Epigenetics and epigenomics in diabetic kidney disease and metabolic memory | 2019/03/20 | English | 302 |
| The role of neutrophils and NETosis in autoimmune and renal diseases | 2016/05/31 | English | 300 |
| Fluid balance and acute kidney injury | 2009/12/22 | English | 299 |
| Obesity, kidney dysfunction and hypertension: mechanistic links | 2019/04/23 | English | 296 |
| Single-cell RNA sequencing for the study of development, physiology and disease | 2018/05/22 | English | 296 |
| Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia | 2019/05/08 | English | 288 |
| The global burden of chronic kidney disease: estimates, variability and pitfalls | 2016/12/12 | English | 278 |
| Metabolic reprogramming in clear cell renal cell carcinoma | 2017/05/08 | English | 277 |
| Acute kidney injury: what's the prognosis? | 2011/02/22 | English | 276 |
| Endothelium structure and function in kidney health and disease | 2019/01/03 | English | 275 |
| The impact of donor-specific anti-HLA antibodies on late kidney allograft failure | 2012/04/17 | English | 274 |
| Innate immunity in diabetes and diabetic nephropathy | 2015/11/16 | English | 270 |
| The renaissance of complement therapeutics | 2017/12/04 | English | 269 |
| MicroRNAs in kidney physiology and disease | 2014/11/11 | English | 268 |